VARIATION IN USE OF HIGH-FLOW NASAL CANNULA AND NONINVASIVE VENTILATION IN COVID-19

ABSTRACT

B Introduction: b Despite critical care guidelines supporting the use of high-flow nasal cannula (HFNC) and non-invasive ventilation (NIV) in patients with acute respiratory failure from coronavirus disease of 2019 (COVID-19), concerns surrounding aerosolization of viral particles, and patient self-inflicted lung injury likely influenced use across hospitals. Among 5311 patients who received HFNC and/or NIV, 2772 (52%) did not receive invasive mechanical ventilation and survived to hospital discharge. B Conclusions: b Hospital variation in use of HFNC and NIV for acute respiratory failure secondary to COVID-19 was large, and was not associated with progression to invasive mechanical ventilation or mortality. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)